Dubrow R, Darefsky AS (2011) Demographic variation in incidence of adult glioma by subtype, United States, 1992–2007. BMC Cancer 11. https://doi.org/10.1186/1471-2407-11-325

Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS (2018) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011–2015. Neuro Oncol 20(suppl_4):iv1–iv86. https://doi.org/10.1093/neuonc/noy131

Article  PubMed  PubMed Central  Google Scholar 

Ostrom QT, Cote DJ, Ascha M, Kruchko C, Barnholtz-Sloan JS (2018) Adult glioma incidence and survival by race or ethnicity in the United States from 2000 to 2014. JAMA Oncol 4(9):1254–1262. https://doi.org/10.1001/jamaoncol.2018.1789

Article  PubMed  PubMed Central  Google Scholar 

Ortman JM, Velkoff VA, Hogan H (2014) An aging nation: the older population in the United States. Econ Stat Adm US Dep Commer 1964:1–28 (census.gov)

Google Scholar 

Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma. N Engl J Med 352(10):987–996. https://doi.org/10.1056/NEJMoa043330

Article  CAS  PubMed  Google Scholar 

Parsons DW, Jones S, Zhang X et al (2008) An integrated genomic analysis of human glioblastoma multiforme. Science (80- ) 321(5897):1807–1812. https://doi.org/10.1126/science.1164382

Louis DN, Perry A, Reifenberger G et al (2016) The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–820. https://doi.org/10.1007/s00401-016-1545-1

Article  PubMed  Google Scholar 

Eckel-Passow JE, Lachance DH, Molinaro AM et al (2015) Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med 372(26):2499–2508. https://doi.org/10.1056/NEJMoa1407279

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brat DJ, Verhaak RGW, Aldape K (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. https://doi.org/10.1056/NEJMoa1402121. https://www.nejm.org/doi/10.1056/NEJMoa1402121. Accessed 25 Jun 2023

Louis DN, Perry A, Burger P et al (2014) International Society Of Neuropathology-Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol 24(5):429–435. https://doi.org/10.1111/bpa.12171

Article  PubMed  PubMed Central  Google Scholar 

Vaupel JW, Manton KG, Stallard E (1979) The impact of heterogeneity in individual frailty on the dynamics of mortality. Demography 16(3):439–454

Article  CAS  PubMed  Google Scholar 

Karam J, Tsiouris A, Shepard A, Velanovich V, Rubinfeld I (2013) Simplified frailty index to predict adverse outcomes and mortality in vascular surgery patients. Ann Vasc Surg 27(7):904–908. https://doi.org/10.1016/j.avsg.2012.09.015

Article  PubMed  Google Scholar 

Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K (2013) Frailty in elderly people. Lancet 381(9868):752–762. https://doi.org/10.1016/S0140-6736(12)62167-9

Article  PubMed  Google Scholar 

Cloney M, D’Amico R, Lebovic J et al (2016) Frailty in geriatric glioblastoma patients: a predictor of operative morbidity and outcome. World Neurosurg 89:362–367. https://doi.org/10.1016/j.wneu.2015.12.096

Article  PubMed  Google Scholar 

Youngerman BE, Neugut AI, Yang J, Hershman DL, Wright JD, Bruce JN (2018) The modified frailty index and 30-day adverse events in oncologic neurosurgery. J Neurooncol 136(1):197–206. https://doi.org/10.1007/s11060-017-2644-0

Article  PubMed  Google Scholar 

Huq S, Khalafallah AM, Jimenez AE et al (2020) Predicting postoperative outcomes in brain tumor patients with a 5-factor modified frailty index. Neurosurgery 88(1):147–154. https://doi.org/10.1093/neuros/nyaa335

Article  PubMed  PubMed Central  Google Scholar 

Mellinghoff IK, Chang SM, Jaeckle KA, van den Bent M (2022) Isocitrate Dehydrogenase Mutant Grade II and III Glial Neoplasms. Hematol Oncol Clin North Am 36(1):95–111. https://doi.org/10.1016/j.hoc.2021.08.008

Article  PubMed  Google Scholar 

Brat DJ, Aldape K, Colman H et al (2020) cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas. Acta Neuropathol 139(3):603–608. https://doi.org/10.1007/s00401-020-02127-9

Article  PubMed  PubMed Central  Google Scholar 

Subramaniam S, Aalberg JJ, Soriano RP, Divino CM (2018) New 5-factor modified frailty index using American College of Surgeons NSQIP data. J Am Coll Surg 226(2):173–181

Article  PubMed  Google Scholar 

Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383

Article  CAS  PubMed  Google Scholar 

Weaver DJ, Malik AT, Jain N, Yu E, Kim J, Khan SN (2019) The modified 5-Item frailty index: a concise and useful tool for assessing the impact of frailty on postoperative morbidity following elective posterior lumbar fusions. World Neurosurg 124:e626–e632. https://doi.org/10.1016/j.wneu.2018.12.168

Article  PubMed  Google Scholar 

Traven SA, Reeves RA, Sekar MG, Slone HS, Walton ZJ (2019) New 5-factor modified frailty index predicts morbidity and mortality in primary hip and knee arthroplasty. J Arthroplasty 34(1):140–144. https://doi.org/10.1016/j.arth.2018.09.040

Article  PubMed  Google Scholar 

Robinson TN, Eiseman B, Wallace JI et al (2009) Redefining geriatric preoperative assessment using frailty, disability and co-morbidity. Ann Surg 250(3). https://journals.lww.com/annalsofsurgery/Fulltext/2009/09000/Redefining_Geriatric_Preoperative_Assessment_Using.13.aspx. Accessed 25 Jun 2023

Ening G, Osterheld F, Capper D, Schmieder K, Brenke C (2015) Charlson comorbidity index: an additional prognostic parameter for preoperative glioblastoma patient stratification. J Cancer Res Clin Oncol 141(6):1131–1137. https://doi.org/10.1007/s00432-014-1907-9

Article  CAS  PubMed  Google Scholar 

Hall WH, Ramachandran R, Narayan S, Jani AB, Vijayakumar S (2004) An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer 4:1–8. https://doi.org/10.1186/1471-2407-4-94

Article  Google Scholar 

Schag CC, Heinrich RL, Ganz PA (1984) Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol 2(3):187–193

Article  CAS  PubMed  Google Scholar 

Banks JL, Marotta CA (2007) Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke 38(3):1091–1096

Article  PubMed  Google Scholar 

Miller JJ, Gonzalez Castro LN, McBrayer S et al (2022) Isocitrate dehydrogenase (IDH) mutant gliomas: a society for neuro-oncology (SNO) consensus review on diagnosis, management, and future directions. Neuro Oncol 25(1):4–25. https://doi.org/10.1093/neuonc/noac207

Article  CAS  PubMed Central  Google Scholar 

Miller KD, Ostrom QT, Kruchko C et al (2021) Brain and other central nervous system tumor statistics, 2021. CA A Cancer J Clin 71(5):381–406. https://doi.org/10.3322/caac.21693

Article  Google Scholar 

Tabouret E, Chinot O, Metellus P, Tallet A, Viens P, Gonçalves A (2012) Recent trends in epidemiology of brain metastases: an overview. Anticancer Res 32(11):4655–4662

PubMed  Google Scholar 

Jiang B, Chaichana K, Veeravagu A, Chang SD, Black KL, Patil CG (2017) Biopsy versus resection for the management of low-grade gliomas. Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group, ed. Cochrane Database Syst Rev 2020(6). https://doi.org/10.1002/14651858.CD009319.pub3

Grabowski MM, Recinos PF, Nowacki AS et al (2014) Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma: Clinical article. J Neurosurg JNS 121(5):1115–1123. https://doi.org/10.3171/2014.7.JNS132449

Article  Google Scholar 

Weller M, van den Bent M, Preusser M et al (2021) EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol 18(3):170–186. https://doi.org/10.1038/s41571-020-00447-z

Article  PubMed  Google Scholar 

Khalafallah AM, Huq S, Jimenez AE, Brem H, Mukherjee D. The 5-factor modified frailty index: an effective predictor of mortality in brain tumor patients. J Neurosurg. Published online 2020:1–9. https://doi.org/10.3171/2020.5.jns20766

Yan H, Parsons DW, Jin G et al (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360(8):765–773. https://doi.org/10.1056/NEJMoa0808710

Article  CAS  PubMed  PubMed Central  Google Scholar 

Momeni F, Abedi-Firouzjah R, Farshidfar Z, Taleinezhad N, Ansari L, Razmkon A, Banaei A, Mehdizadeh A (2021) Differentiating between low- and high-grade glioma tumors measuring apparent diffusion coefficient values in various regions of the brain. Oman Med J 36(2):e251. https://doi.org/10.5001/omj.2021.59.PMID:33936779;PMCID:PMC8077446